Pay in 4 interest-free payments of $87.50 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The peptide sequence VGVTETP corresponds to positions 103-109 of the mature IFNα2b protein with α-GalNAc glycosylation (Tn Antigen) ocurring at Thr105
enabling enzymatic extension to sialylated and fucosylated structures such as sialyl-LacNAc and Lewis antigens
C36H59N7O18 / 877
corresponding to the α-Gal epitope (Galα1-3Galβ1-4GlcNAc) that is the target of naturally occurring human anti-Gal antibodies and is central to xenotransplantation and anti-Gal immunology research
C41H66N8O19 / 975 / HHV1-gB(UniProt ID P08665) synthetic glycopeptide HSV1-gB fragment (Thr53-Pro57
GP000105: MUC1(126-149)-STn(139,140) Pack Size:1 mg The peptide sequence VGVTETP correspondsC133H209N33O58 3198. 27 MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Pro126 Gly149; UniProt position 126 149, aa length 24) from the variable number tandem repeat (TR) domain. The fragment contains tumour associated carbohydrate antigen (TACA), Sialyl Tn or STn (Neu5Ac2 6GalNAc O Ser) at Ser140 and Neu5Ac2 6GalNAc O Thr at Thr139. The C terminus is carboxylic acid. MUC1(126 149) STn(139,140) Mucin1; Synthetic MUC 1 (di STn) glycopeptide
